FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116732514> ?p ?o ?g. }

• W2116732514 endingPage "1348" @default.
• W2116732514 startingPage "1343" @default.
• W2116732514 abstract "Administration of erythropoietin (EPO) has been linked to cerebrovascular events. EPO reduces vascular conductance, possibly because of the increase in hematocrit. Whether EPO in itself affects the vasculature remains unknown; here it was evaluated in healthy males by determining systemic and cerebrovascular variables following acute (30,000 IU/d for 3 d; n=8) and chronic (5000 IU/week for 13 wk; n=8) administration of EPO, while the responsiveness of the vasculature was challenged during cycling exercise, with and without hypoxia. Prolonged administration of EPO increased hematocrit from 42.5 ± 3.7 to 47.6 ± 4.1% (P<0.01), whereas hematocrit was unaffected following acute EPO administration. Yet, the two EPO regimes increased arterial pressure similarly (by 8±4 and 7±3 mmHg, respectively; P=0.01) through reduced vascular conductance (by 7±3 and 5±2%; P<0.05). Also, both EPO regimes widened the arterial-to-jugular O(2) differences at rest as well as during normoxic and hypoxic exercise (P<0.01), which indicated reduced cerebral blood flow despite preserved dynamic cerebral autoregulation, and an increase in middle cerebral artery mean blood flow velocity (P<0.05), therefore, reflected vasoconstriction. Thus, administration of EPO to healthy humans lowers systemic and cerebral conductance independent of its effect on hematocrit." @default.
• W2116732514 created "2016-06-24" @default.
• W2116732514 creator A5005926479 @default.
• W2116732514 creator A5013323728 @default.
• W2116732514 creator A5021762389 @default.
• W2116732514 creator A5028178460 @default.
• W2116732514 creator A5050361725 @default.
• W2116732514 creator A5060382357 @default.
• W2116732514 creator A5066850019 @default.
• W2116732514 date "2011-12-09" @default.
• W2116732514 modified "2023-09-23" @default.
• W2116732514 title "Both acute and prolonged administration of EPO reduce cerebral and systemic vascular conductance in humans" @default.
• W2116732514 cites W1497672261 @default.
• W2116732514 cites W1515497590 @default.
• W2116732514 cites W1534550394 @default.
• W2116732514 cites W1583917628 @default.
• W2116732514 cites W1899050407 @default.
• W2116732514 cites W1979804841 @default.
• W2116732514 cites W1996273727 @default.
• W2116732514 cites W2024986103 @default.
• W2116732514 cites W2036253606 @default.
• W2116732514 cites W2047589954 @default.
• W2116732514 cites W2080845943 @default.
• W2116732514 cites W2101311724 @default.
• W2116732514 cites W2103320383 @default.
• W2116732514 cites W2106589023 @default.
• W2116732514 cites W2109447375 @default.
• W2116732514 cites W2114919659 @default.
• W2116732514 cites W2116554711 @default.
• W2116732514 cites W2124880827 @default.
• W2116732514 cites W2130991130 @default.
• W2116732514 cites W2131519787 @default.
• W2116732514 cites W2157623707 @default.
• W2116732514 cites W2159277211 @default.
• W2116732514 cites W2159916913 @default.
• W2116732514 cites W2162264368 @default.
• W2116732514 cites W2315329949 @default.
• W2116732514 cites W2403237581 @default.
• W2116732514 doi "https://doi.org/10.1096/fj.11-193508" @default.
• W2116732514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22159148" @default.
• W2116732514 hasPublicationYear "2011" @default.
• W2116732514 type Work @default.
• W2116732514 sameAs 2116732514 @default.
• W2116732514 citedByCount "17" @default.
• W2116732514 countsByYear W21167325142013 @default.
• W2116732514 countsByYear W21167325142014 @default.
• W2116732514 countsByYear W21167325142015 @default.
• W2116732514 countsByYear W21167325142016 @default.
• W2116732514 countsByYear W21167325142018 @default.
• W2116732514 countsByYear W21167325142021 @default.
• W2116732514 countsByYear W21167325142022 @default.
• W2116732514 crossrefType "journal-article" @default.
• W2116732514 hasAuthorship W2116732514A5005926479 @default.
• W2116732514 hasAuthorship W2116732514A5013323728 @default.
• W2116732514 hasAuthorship W2116732514A5021762389 @default.
• W2116732514 hasAuthorship W2116732514A5028178460 @default.
• W2116732514 hasAuthorship W2116732514A5050361725 @default.
• W2116732514 hasAuthorship W2116732514A5060382357 @default.
• W2116732514 hasAuthorship W2116732514A5066850019 @default.
• W2116732514 hasConcept C126322002 @default.
• W2116732514 hasConcept C134018914 @default.
• W2116732514 hasConcept C157767197 @default.
• W2116732514 hasConcept C164705383 @default.
• W2116732514 hasConcept C178790620 @default.
• W2116732514 hasConcept C185592680 @default.
• W2116732514 hasConcept C2775841333 @default.
• W2116732514 hasConcept C2778534260 @default.
• W2116732514 hasConcept C2779961880 @default.
• W2116732514 hasConcept C2780959883 @default.
• W2116732514 hasConcept C42219234 @default.
• W2116732514 hasConcept C540031477 @default.
• W2116732514 hasConcept C541997718 @default.
• W2116732514 hasConcept C58245268 @default.
• W2116732514 hasConcept C71924100 @default.
• W2116732514 hasConcept C7836513 @default.
• W2116732514 hasConcept C84393581 @default.
• W2116732514 hasConceptScore W2116732514C126322002 @default.
• W2116732514 hasConceptScore W2116732514C134018914 @default.
• W2116732514 hasConceptScore W2116732514C157767197 @default.
• W2116732514 hasConceptScore W2116732514C164705383 @default.
• W2116732514 hasConceptScore W2116732514C178790620 @default.
• W2116732514 hasConceptScore W2116732514C185592680 @default.
• W2116732514 hasConceptScore W2116732514C2775841333 @default.
• W2116732514 hasConceptScore W2116732514C2778534260 @default.
• W2116732514 hasConceptScore W2116732514C2779961880 @default.
• W2116732514 hasConceptScore W2116732514C2780959883 @default.
• W2116732514 hasConceptScore W2116732514C42219234 @default.
• W2116732514 hasConceptScore W2116732514C540031477 @default.
• W2116732514 hasConceptScore W2116732514C541997718 @default.
• W2116732514 hasConceptScore W2116732514C58245268 @default.
• W2116732514 hasConceptScore W2116732514C71924100 @default.
• W2116732514 hasConceptScore W2116732514C7836513 @default.
• W2116732514 hasConceptScore W2116732514C84393581 @default.
• W2116732514 hasFunder F4320321708 @default.
• W2116732514 hasFunder F4320321999 @default.
• W2116732514 hasFunder F4320324456 @default.
• W2116732514 hasIssue "3" @default.
• W2116732514 hasLocation W21167325141 @default.

• next